For research use only. Not for therapeutic Use.
CIDD-0149897 is a potent, selective and brain-penetrant ERβ agonist. CIDD-0149897 exert antitumor functions in glioblastoma[1].
| Catalog Number | I040611 |
| CAS Number | 2862784-20-9 |
| Synonyms | (2Z)-6-(3-fluoro-4-hydroxyphenyl)-2-hydroxyimino-3H-inden-1-one |
| Molecular Formula | C15H10FNO3 |
| Purity | ≥95% |
| InChI | InChI=1S/C15H10FNO3/c16-12-6-9(3-4-14(12)18)8-1-2-10-7-13(17-20)15(19)11(10)5-8/h1-6,18,20H,7H2/b17-13- |
| InChIKey | XIWQAWUOXXYWMB-LGMDPLHJSA-N |
| SMILES | C1C2=C(C=C(C=C2)C3=CC(=C(C=C3)O)F)C(=O)C1=NO |
| Reference | [1]. Pratap UP, et, al. Preclinical Development of Brain Permeable ERβ Agonist for the Treatment of Glioblastoma. Mol Cancer Ther. 2023 Nov 1;22(11):1248-1260. |
